Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving cholesterol
Reexamination Certificate
2007-02-20
2007-02-20
Chan, Christina (Department: 1644)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving cholesterol
C436S507000, C436S515000, C436S516000, C436S517000
Reexamination Certificate
active
10019087
ABSTRACT:
A method for diagnosing a condition of a patient involves the steps of (a) adding one or more reagents to a test sample from a patient, the test samples comprising at least part of a blood sample from the patient, in order to cause formation of a complex comprising at least one acute phase protein and at least one human lipoprotein, while causing substantially no fiber polymerization; (b) measuring the formation of the complex over time so as to derive a time-dependent measurement profile, and (c) determining a slope and/or total change in the time-dependent measurement profile, so as to diagnose a condition of the patient. A greater formation of the complex is correlated to increased probability of death of the patient.
REFERENCES:
patent: 3307392 (1967-03-01), Owen et al.
patent: 3458287 (1969-07-01), Gross et al.
patent: 3658480 (1972-04-01), Kane et al.
patent: 4040788 (1977-08-01), Simons et al.
patent: 4047890 (1977-09-01), Eichelberger et al.
patent: 4199748 (1980-04-01), Bacus
patent: 4217107 (1980-08-01), Saito et al.
patent: 4279616 (1981-07-01), Saito et al.
patent: 4289498 (1981-09-01), Baughman et al.
patent: 4766083 (1988-08-01), Miyashita et al.
patent: 4782014 (1988-11-01), Serban et al.
patent: 4902630 (1990-02-01), Bennett et al.
patent: 4965725 (1990-10-01), Rutenberg
patent: 4998535 (1991-03-01), Selker et al.
patent: 5003065 (1991-03-01), Merritt et al.
patent: 5055412 (1991-10-01), Proksch
patent: 5156974 (1992-10-01), Grossman et al.
patent: 5218529 (1993-06-01), Meyer et al.
patent: 5221628 (1993-06-01), Anderson et al.
patent: 5358852 (1994-10-01), Wu
patent: 5388164 (1995-02-01), Yonekawa et al.
patent: 5473551 (1995-12-01), Sato et al.
patent: 5473732 (1995-12-01), Chang
patent: 5500345 (1996-03-01), Soe et al.
patent: 5506146 (1996-04-01), Josef
patent: 5525477 (1996-06-01), Hassouna
patent: 5526111 (1996-06-01), Collins et al.
patent: 5553616 (1996-09-01), Ham et al.
patent: 5563983 (1996-10-01), Nozaki et al.
patent: 5567596 (1996-10-01), Diamond et al.
patent: 5591403 (1997-01-01), Gavin et al.
patent: 5593897 (1997-01-01), Potempa et al.
patent: 5646046 (1997-07-01), Fischer et al.
patent: 5670329 (1997-09-01), Oberhardt
patent: 5705395 (1998-01-01), Griffin et al.
patent: 5708591 (1998-01-01), Givens et al.
patent: 5715821 (1998-02-01), Faupel
patent: 5716795 (1998-02-01), Matschiner
patent: 5834223 (1998-11-01), Griffin et al.
patent: 5856114 (1999-01-01), Mann et al.
patent: 5862304 (1999-01-01), Ravdin et al.
patent: 5981285 (1999-11-01), Carroll et al.
patent: 6010911 (2000-01-01), Baugh et al.
patent: 6040147 (2000-03-01), Ridker et al.
patent: 6101449 (2000-08-01), Givens et al.
patent: 6156530 (2000-12-01), R.ang.nby
patent: 6269313 (2001-07-01), Givens et al.
patent: 6321164 (2001-11-01), Braun et al.
patent: 6429017 (2002-08-01), Toh et al.
patent: 2635081 (1978-02-01), None
patent: 3502 878 (1985-01-01), None
patent: 0 115 459 (1984-08-01), None
patent: 0 434 377 (1991-06-01), None
patent: 0 525 273 (1993-02-01), None
patent: 818 680 (1998-01-01), None
patent: 841 566 (1998-05-01), None
patent: 2364 453 (1976-09-01), None
patent: 2005014 (1979-04-01), None
patent: 59-203959 (1984-11-01), None
patent: 60-114768 (1985-06-01), None
patent: 61-272655 (1986-12-01), None
patent: 05-180835 (1991-12-01), None
patent: 06-027115 (1992-07-01), None
patent: 04-254760 (1992-09-01), None
patent: 06-249855 (1994-09-01), None
patent: 10-104239 (1996-09-01), None
patent: 2012877 (1991-04-01), None
patent: 2061953 (1996-06-01), None
patent: 2070327 (1996-12-01), None
patent: 590665 (1976-02-01), None
patent: 1076086 (1984-02-01), None
patent: 1691741 (1989-08-01), None
patent: 1777089 (1990-06-01), None
patent: WO 86/06840 (1986-11-01), None
patent: WO 89/09628 (1989-10-01), None
patent: WO 91/00872 (1991-01-01), None
patent: WO 91/01383 (1991-02-01), None
patent: WO 91/01497 (1991-02-01), None
patent: WO 91/02812 (1991-03-01), None
patent: WO 91/05874 (1991-05-01), None
patent: WO 91/08460 (1991-06-01), None
patent: WO 91/16453 (1991-10-01), None
patent: WO 93/07491 (1993-04-01), None
patent: WO 93/09438 (1993-05-01), None
patent: WO 93/24530 (1993-12-01), None
patent: WO 94/07145 (1994-03-01), None
patent: WO 94/11714 (1994-05-01), None
patent: WO 94/16095 (1994-07-01), None
patent: WO 95/05590 (1995-02-01), None
patent: WO 95/08121 (1995-03-01), None
patent: WO 96/42018 (1995-09-01), None
patent: WO 95/30154 (1995-11-01), None
patent: WO 96/06624 (1996-03-01), None
patent: WO 96/14581 (1996-05-01), None
patent: WO 96/21740 (1996-07-01), None
patent: WO 96/41291 (1996-12-01), None
patent: WO 97/04317 (1997-02-01), None
patent: WO 97/20066 (1997-06-01), None
patent: WO 97/34698 (1997-09-01), None
patent: WO 98/09628 (1998-03-01), None
patent: WO 99/34208 (1999-07-01), None
patent: WO 99/47699 (1999-09-01), None
Stryer et al, in Biochemistry, Third edition, W H Freeman Company, New York, pp. 31-33, 1998.
Ngo et al, 1994, The Protein Folding Problem and Tertiary Structure Prediction, pp. 492-495.
Kuby et al., 1994, Immunology, second edition, pp. 85-96.
Row et al, Clin Exp Immunol 58(1): 237-44, 1984.
Li et al, Biochemical and Biophys Research Communications 224: 249-252, 1998.
Ridker et al, Circulation 97: 2007-2011, 1998.
Artherotech,VAP/CAD Lipoprotein Risk Assessment Test and Sample of VAP Profile, http://www.artherotech.com/risk—assessment.html.
Cabana, et al., Effects of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins,J. Lipid Res., 30:39-49 (1989).
Cabana, et al., Inflammation-induced changes in rabbit CRP and plasma lipoproteins,J. Immunol., 130(4):1736-1742 (Apr. 1983).
Lindh, et al., Agglutinate formation in serum samples mixed with intravenous fat emulsions,Crit Care Med., 13(3):151-154 (Mar. 1985).
Malle, et al., Serum amyloid A (SAA): an acute phase protein and apolipoprotein,Atherosclerosis, 102:131-146 (1993).
Maury et al., Clinical usefulness of serum amyloid A and C-reactive protein measurements in inflammatory disorders a comparative study,Market Proteins in Inflammation Proceedings, Symposium, Lyon, France, 3:Abstract only-(1985), 153-156.
McCarty, M., Historical perspective on C-reactive protein,Ann N.Y. Acad Sci., 389:1-10 (1982).
McDonald, et al., A monoclonal antibody sandwich immunoassay for serum amyloid A (SAA) protein,J. Immunol. Methods, 144:149-155 (Nov. 22, 1991).
Pepys, et al., C-reactive protein: binding to lipids and lipoproteins,Int Rev.Exp.Pathol., 27:83-111 (1985).
Preciado-Pratt et al. et al., Serum amyloid A complexed with extracellular matrix induces the secretion of tumor necrosis factor-alpha by human T-lymphocytes,Letters in Peptide Science, 5:349-355 (Oct. 1988).
Richter, et al., The fat emulsion agglutination test: a reliable and cost effective alternative to the latex agglutination test for rapid bedside CRP measurement,Clin. Chim. Acta, 261:141-148 (May 1997).
Robin et al., Prognostic value of waveform analysis in the intensive care setting,Intensive Care Med., 25(Suppl 1):S63 (1999).
Rowe, et al., Agglutination of intravenous lipid emulsion (‘Intralipid’) and plasma lipoproteins by C-reactive protein,Clin. Exp. Immunol., 66:241-247 (1986).
Rowe, et al., Circulating human C-reactive protein binds very low density lipoproteins,Clin.Exp.Immunol., 58:237-244 (1984).
Rowe, et al.,In vivoturnover studies of C-reactive protein and lipoproteins in the rabbit,Clin.Exp.Immunol., 58:245-252 (1984).
Rowe, et al., Rabbit and rat C-reactive proteins bind apolipoprotein B-containing lipoproteins,J.Exp.Med., 159:604-616 (Feb. 1984).
Rybarska, J., Konieczny, L., Piekarska, B., Stopa, B., and Roterman, I. et al., The detection of specific acute phase serum protein complexes and immune complexes by congo red binding,J.Physiol Pharmacol., 46(2):221-231 (Jun. 1995).
Sammalkorpi, et al., Lipoproteins and acute phase response during acute infection. Interrelationships between C-reactive protein and serum amyloid-A protein and lipoproteins,Ann Med., 22:397-401 (1990).
Cabana, et al., Interaction of very low density lipoproteins (VLDL) with rabbit C-r
Downey Colin
Fischer Timothy J.
Nesheim Mike
Samis John A.
Tejidor Liliana
bioMerieux Inc.
Chan Christina
Huynh Phuong
Myers Bigel Sibley & Sajovec P.A.
LandOfFree
Method for detecting a lipoprotein-acute phase protein... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for detecting a lipoprotein-acute phase protein..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for detecting a lipoprotein-acute phase protein... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3858484